LONG-TERM EFFICACY AND SAFETY OF RISANKIZUMAB: A RETROSPECTIVE, MULTICENTER, REAL-WORLD STUDY

被引:0
|
作者
Kim, Han-Na [1 ]
Woo, Bin [1 ]
Kim, Young Chan [1 ]
Kim, Dai-Hyun [1 ]
Son, Sang Wook [1 ]
Baek, Yoo Sang [1 ]
机构
[1] Korea Univ, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P-027
引用
收藏
页数:102
相关论文
共 50 条
  • [31] Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
    Galluzzo, Marco
    Trovato, Emanuele
    Talamonti, Marina
    Caldarola, Giacomo
    Di Nardo, Lucia
    Lazzeri, Laura
    Mugheddu, Cristina
    Burlando, Martina
    Balestri, Riccardo
    Bernardini, Nicoletta
    Biondi, Gabriele
    Vellucci, Laura
    Russo, Filomena
    De Simone, Clara
    Paganini, Claudia
    Rech, Giulia
    Cozzani, Emanuele Claudio
    Atzori, Laura
    Montesu, Maria Antonia
    Potenza, Concetta
    Chiricozzi, Andrea
    Rubegni, Pietro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [32] Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
    Mazzotta, Marco
    Krasniqi, Eriseld
    Barchiesi, Giacomo
    Pizzuti, Laura
    Tomao, Federica
    Barba, Maddalena
    Vici, Patrizia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [33] Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
    Levra, Stefano
    Guida, Giuseppe
    Sprio, Andrea Elio
    Crosa, Flavio
    Ghio, Paolo Carlo
    Bertolini, Francesca
    Carriero, Vitina
    Albera, Carlo
    Ricciardolo, Fabio Luigi Massimo
    BIOMEDICINES, 2022, 10 (12)
  • [34] Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting
    Martin, Peter
    Barr, Paul
    Kahl, Brad S.
    Pathak, Ashutosh
    BLOOD, 2016, 128 (22)
  • [35] Long-term safety experience with bendamustine for injection in a real-world setting
    Martin, Peter
    Barr, Paul M.
    James, Leonard
    Pathak, Ashutosh
    Kahl, Brad
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 647 - 650
  • [36] Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
    Orsini, Diego
    Caldarola, Giacomo
    Dattola, Annunziata
    Campione, Elena
    Bernardini, Nicoletta
    Frascione, Pasquale
    De Simone, Clara
    Richetta, Antonio G.
    Galluzzo, Marco
    Skroza, Nevena
    Assorgi, Chiara
    Amore, Emanuele
    Falco, Gennaro M.
    Shumak, Ruslana Gaeta
    Artosi, Fabio
    Maretti, Giulia
    Potenza, Concetta
    Bianchi, Luca
    Pellacani, Giovanni
    Peris, Ketty
    Bonifati, Claudio
    Graceffa, Dario
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [37] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
    Emily K. Haque
    Aaminah Azhar
    John Corbett
    Jillian Frieder
    Xuan Wang
    Alan Menter
    Dermatology and Therapy, 2020, 10 : 1121 - 1135
  • [38] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
    Haque, Emily K.
    Azhar, Aaminah
    Corbett, John
    Frieder, Jillian
    Wang, Xuan
    Menter, Alan
    DERMATOLOGY AND THERAPY, 2020, 10 (05) : 1121 - 1135
  • [39] Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience
    Stefanutti, Claudia
    Chan, Dick C.
    Di Giacomo, Serafina
    Morozzi, Claudia
    Watts, Gerald F.
    PHARMACEUTICALS, 2022, 15 (11)
  • [40] A Prospective Multicenter Study to Assess the Long-Term Safety and Efficacy of Sirolimus-Coated Balloon in Treatment of In-Stent Restenosis in Unselected Real-World Patients
    Latib, Azeem
    Dani, Sameer
    Parikh, Keyur
    Kumar, Prathrap
    Shetty, Ranjan
    Hiremath, Jagdish
    Shah, Dinesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B273 - B273